SEC Comment Letter for RENOVARO INC. (RENB) (CIK 0001527728) (LNAI) — Nov 4, 2024
RENOVARO INC. (RENB) (CIK 0001527728)
Date: Nov. 4, 2024 · CIK: 0001527728 · Accession: 0000000000-24-012236
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282898
Letter
November 4, 2024 David Weinstein Chief Executive Officer Renovaro Inc. 2080 Century Park East, Suite 906 Los Angeles, CA 90067 Re:Renovaro Inc. Registration Statement on Form S-3 Filed October 30, 2024 File No. 333-282898 Dear David Weinstein: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Erin Fogarty
Show Raw Text
November 4, 2024
David Weinstein
Chief Executive Officer
Renovaro Inc.
2080 Century Park East, Suite 906
Los Angeles, CA 90067
Re:Renovaro Inc.
Registration Statement on Form S-3
Filed October 30, 2024
File No. 333-282898
Dear David Weinstein:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Erin Fogarty